Dow Jones

40 003,59

0,34%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Millennium Pharmaceuticals (MM) (MLNM)
Millennium Pharmaceuticals (MM) (MLNM) Actualités

MLNM

Millennium Pharmaceuticals (MM) (MLNM)

Millennium Pharmaceuticals (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:MLNM

1 2 3 4 5 6 7 8 9 10 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
15/05/2008	21h50	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
14/05/2008	23h27	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Current report filing (8-K)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
14/05/2008	23h08	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Termination of Registration of a Class of Security under Section 12(g) (15-12G)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
14/05/2008	22h32	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc-Notification filed by National Security Exchange to report the removal from listing a... (25-NSE)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
14/05/2008	19h20	PR Newswire (US)	Takeda Completes Acquisition of Millennium	NASDAQ:MLNM
14/05/2008	16h02	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
14/05/2008	15h30	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
14/05/2008	13h00	PR Newswire (US)	Takeda Completes Subsequent Offering Period for Shares of Millennium Pharmaceuticals, Inc.	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
12/05/2008	23h06	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Quarterly Report (10-Q)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
09/05/2008	08h21	PR Newswire (US)	Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
06/05/2008	22h00	PR Newswire (US)	Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardi	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
05/05/2008	23h42	PR Newswire (US)	Standard & Poor's Announces Changes to U.S. Indices	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
02/05/2008	20h21	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
29/04/2008	14h00	PR Newswire (US)	Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting Period	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
11/04/2008	23h08	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Tender offer statement by Third Party (SC TO-T)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
11/04/2008	22h19	PR Newswire (US)	Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium	NASDAQ:MLNM
10/04/2008	23h13	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Written communication by the subject company relating to a third party tender offer (SC14D9C)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
10/04/2008	21h12	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Written communication relating to an issuer or third party (SC TO-C)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
10/04/2008	16h26	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Amended Securities Registration (section 12(g)) (8-A12G/A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
10/04/2008	08h15	PR Newswire (US)	Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
10/04/2008	08h06	PR Newswire (US)	Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
07/04/2008	19h06	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
07/04/2008	19h02	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Proxy Statement (definitive) (DEF 14A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
28/03/2008	21h41	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Amended Statement of Changes in Beneficial Ownership (4/A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
17/03/2008	12h01	PR Newswire (US)	Millennium Expands IBD Franchise with Addition of New Development Candidate	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
13/03/2008	12h01	PR Newswire (US)	Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly D	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
12/03/2008	13h01	PR Newswire (US)	Eleventh Annual Lehman Brothers Global Healthcare Conference to Webcast Millennium Presentation	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
10/03/2008	14h01	PR Newswire (US)	Cowen & Company 28th Annual Healthcare Conference to Webcast Millennium Presentation	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
29/02/2008	21h37	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Annual Report (10-K)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
28/02/2008	23h33	PR Newswire (US)	2008 Susquehanna Healthcare Conference to Webcast Millennium Presentation	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)